ArticleCancer chemotherapy and pharmacology2019

CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors.

Yogesh T Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.